請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/60250
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 陳忠仁(Chung-Jen Chen) | |
dc.contributor.author | Chia-Kang Chen | en |
dc.contributor.author | 陳佳康 | zh_TW |
dc.date.accessioned | 2021-06-16T10:14:15Z | - |
dc.date.available | 2025-07-07 | |
dc.date.copyright | 2020-07-22 | |
dc.date.issued | 2020 | |
dc.date.submitted | 2020-07-07 | |
dc.identifier.citation | 英文文獻 1. Porter, M. E. (1979) 'How competitive forces shape strategy', Harvard Business Review, March/April. 2. Robert M. (2002) Grant. Contemporary Strategy Analysis. 3. Porter M. E. (1980) Competitive Strategy:Techniques for Analyzing Industries and Competitors. New York: Free Press. 4. C. K. Prahalad G. Hamel. (1980) 'The core competence of the Corporation' Harvard Business Review, Jun/July. 5. Genomics Market Size, Share and Industry Analysis By Type, Technology, Application, End-User Regional Forecast, 2019 - 2026. Fortune Business Insight. 6. Genomics Market by Product and Service, Technology, Application, End User - Global Forecast to 2024. Market and Market. 7. Next Generation Sequencing Market: Global Opportunity Analysis and Industry Forecast, 2019–2026. Allied Market Research. 8. Next-Generation Sequencing Services Market by Type, Technology, Application - Forecasts to 2022. Market and Market. 9. Microarray Analysis Market by Product Service, Type, Application, End User - Global Forecast to 2023. Market and Market. 10. Thermo Fisher Scientific 2019 Annual Report 10-K. 11. Illumina At A Glance. 12. Illumina 2019 Q4 Source Book. 13. Illumina 2020 Q1 Source Book. 14. Illumina 2016-2019 Annual Report 10-K. 15. Illumina 2019 Q4 Supplementary Information. 16. Solexa 2005 Annual Report 10K. 17. Deloitte 2016 Global life sciences outlook 18. 2020 EY M A Firepower report. 19. 2019.Q2 Healthcare MoneyTree™ report. 20. 2019.Q4 Healthcare MoneyTree™ report. 21. National Human Genome Research Institute. https://www.genome.gov/ 22. Genetic Engineering Biotechnology News (GEN). https://www.genengnews.com/ 23. Global Cancer Observatory (GCO). https://gco.iarc.fr/ 24. Illumina Official Website. https://www.illumina.com/ 25. Thermo Fisher Scientific Official Website. https://www.thermofisher.com/ 26. Crunchbase. https://www.crunchbase.com/ 27. Genomeweb. https://www.genomeweb.com/ 28. Next Gen Seek. https://nextgenseek.com/amp/ 29. 10X Genomics. https://www.10xgenomics.com/ 30. Federal Trade Commission(FTC). https://www.ftc.gov/ 中文文獻 1. 走過半世紀的基因定序 從研究技術蛻變成為產業支柱,基因線上專刊 5月號/ 2019 2. 華大基因2019年年度報告 3. 資誠 2018精準醫療發展現況與趨勢 全球篇 4. 莊曜宇、盧子彬,臺大電機系科普系列-跨領域研究的結合:生物晶片,2012 5. 王大維,跨領域生物科技應用趨勢系列(二)全球生物晶片產業發展概況,2006 6. 朱文儀、陳建男(譯)Charles W.L. Hill,Melissa A. Schilling,Gareth R. Jones著,策略管理(Strategic Management Theory 12TH Edition),2017 7. 每日頭條. https://kknews.cc/ 8. 環球生技月刊 https://www.gbimonthly.com/ 9. 華大基因官網 https://www.genomics.cn/ 10. 基因線上 https://geneonline.news/ | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/60250 | - |
dc.description.abstract | Illumina公司成立於1998年4月,初期以基因微陣列技術為核心的公司,在2006年透過購併策略,取得關鍵基因定序技術,並持續研發新型定序儀器與耗材,成功轉型為全球最大的基因定序公司。 隨著基因定序的技術持續進步,Illumina公司透過多次購併策略,取得多項技術與產品,並且推動定序價格大幅下降,基因體產業也從原本的科學研究,發展至臨床醫療應用,Illumina公司除了佈局產業上游之外,近年來在中游市場也多有著墨,除提供客戶軟體分析與雲端服務,也在2012年透過另一次購併策略,進入檢測服務市場,計畫為市場提供更好的產品;此外,Illumina也成立第一個基因產業的加速器,並成Illumina創投公司,希望可以提供產業中有潛力的新創公司在資金與經驗上的支持。 本個案研究運用五力分析來辨識基因產業的產業關鍵因素,並探究Illumina的核心能力,以及透過BCG矩陣來檢視各事業單位的定位,並分析其競爭策略,用以解析Illumina公司未來事業發展走向。 | zh_TW |
dc.description.abstract | Illumina was founded in April 1998. At the beginning, the company focused on microarray technology. In 2006, Illumina acquired DNA sequencing technology through merger and acquisition strategies. Illumina continued to develop new sequencing instruments and consumables, and successfully transformed into the world's largest genetic sequencing company. As the technology of DNA sequencing continues to advance, Illumina has acquired multiple technologies and products through merger and acquisition strategies. Illumina has promoted a significant decline in sequencing prices. The genomic industry has also developed from original scientific research to clinical medical applications. Illumina has been in the industry upstream for many years, and it has also deployed the midstream market in recent years. In addition to providing customer software analysis and cloud services, Illumina also entered the genetic testing service market through another merger strategy in 2012, and plan to provide better products for the market. In addition, Illumina also established the first accelerator of the genomic industry and became Illumina Ventures, hoping to provide financial and experience support to potential startups in the industry. This case study uses five forces analysis to identify key industry factors in the genomic industry, explore Illumina's core capabilities, and examine the positioning of each business unit through the BCG matrix, and analyze its competitive strategies to analyze Illumina's future business development strategy. | en |
dc.description.provenance | Made available in DSpace on 2021-06-16T10:14:15Z (GMT). No. of bitstreams: 1 U0001-0707202021130600.pdf: 3983705 bytes, checksum: 336feee6eef90cf43706ba9bb70e3650 (MD5) Previous issue date: 2020 | en |
dc.description.tableofcontents | 口試委員會審定書 # 誌謝 i 中文摘要 ii ABSTRACT iii 目錄 v 圖目錄 viii 表目錄 x 第一章 緒論 1 1.1 研究動機 1 1.2 研究問題與目的 1 1.3 研究方法及限制 2 1.4 研究流程 2 第二章 文獻探討 3 2.1 產業五力分析 3 2.2 企業能耐分析 4 2.3 事業組合分析 4 2.4 競爭策略分析 6 第三章 產業分析 8 3.1 產業概況 8 3.1.1 基因定序市場 8 3.1.2 微陣列市場 11 3.2 產業技術與市場趨勢 12 3.2.1 產業技術 12 3.2.2 市場趨勢 15 3.2.3 生技產業購併 15 3.2.4 生技產業創投 17 3.3 產業主要競爭者分析 19 3.4 五力分析與產業關鍵因素 20 3.4.1 定序平台-儀器與試劑耗材(定序市場上游) 20 3.4.2 定序平台-服務銷售(定序市場中游) 23 3.4.3 微陣列市場 26 第四章 個案分析 29 4.1 公司介紹 29 4.1.1 關於Illumina 29 4.1.2 產品與服務介紹 29 4.1.3 銷售分析 33 4.1.4 營業收入 36 4.2 資源與能力 38 4.2.1 領導力 38 4.2.2 董事會與管理團隊 40 4.2.3 知識產權 41 4.2.4 研發投入 42 4.3 購併策略 43 4.4 合作策略 44 4.5 Illumina Accelerator與Illumina Venture 45 4.5.1 Illumina Accelerator 45 4.5.2 Illumina Venture 46 4.6 事業組合分析 47 4.7 事業競爭策略 50 4.7.1 定序平台-儀器與試劑耗材競爭策略 50 4.7.2 定序平台-服務銷售競爭策略 52 4.7.3 微陣列平台競爭策略 53 第五章 結論與建議 54 5.1 研究結論 54 5.2 研究建議 56 參考文獻 59 附錄 61 | |
dc.language.iso | zh-TW | |
dc.title | 基因體學產業之經營與發展策略分析 - 以Illumina為例 | zh_TW |
dc.title | The Business Strategy Analysis of the Genomics Firm – A Case Study of Illumina | en |
dc.type | Thesis | |
dc.date.schoolyear | 108-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 陳俊忠(Chun-Chung Chen),林俊裕(Jun-You Lin) | |
dc.subject.keyword | 基因定序,微陣列,購併策略,基因體產業,五力分析,BCG矩陣,競爭策略, | zh_TW |
dc.subject.keyword | Illumina,DNA sequencing,microarray,M A strategy,genomic industry,Five Force analysis,BCG matrix,Competitive strategy, | en |
dc.relation.page | 65 | |
dc.identifier.doi | 10.6342/NTU202001372 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2020-07-08 | |
dc.contributor.author-college | 進修推廣學院 | zh_TW |
dc.contributor.author-dept | 生物科技管理碩士在職學位學程 | zh_TW |
顯示於系所單位: | 生物科技管理碩士在職學位學程 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
U0001-0707202021130600.pdf 目前未授權公開取用 | 3.89 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。